
DB Schenker has one of the world’s largest GDP-compliant logistics networks• 157 certificates guaranteeing quality and compliance with standards. Uniform global standards across all operating units. DB Schenker is strengthening its commitment to excellence and compliance with the strict standards and regulations applicable to pharmaceutical supply chains by holding Good Distribution Practice (GDP) certificates for 157 of its operating units. The DB SCHENKER | life+ product portfolio covers the most important markets for global medical product trade, i.e., the Americas, Europe, and Asia.
This number of certificates currently allows DB Schenker to secure 80% of global healthcare sector goods flows, making it one of the world’s largest GDP-compliant logistics networks. The operator can now even better meet the changing needs of the global pharmaceutical industry.
Healthcare is an industry strictly regulated by various guidelines, which is why compliance with GDP requirements is so important. The Good Distribution Practice certificate confirms that DB Schenker follows quality guidelines that ensure the integrity and quality of pharmaceutical products throughout the supply chain. DB Schenker’s internal Global Quality Management System for the healthcare sector incorporates GDP requirements for medicinal products for human and veterinary use and related active substances as defined by the European Union (EU) and the World Health Organization (WHO). The operator guarantees compliance with these requirements through its internal Healthcare Quality Management Directive, which is the formal basis for the DB SCHENKER | life+ service.
– At the end of every healthcare supply chain is a patient. That is why we take special care to ensure that medical products are stored and distributed in accordance with the highest standards. The successful GDP certification of our units is a significant milestone that demonstrates our continuous pursuit of excellence in pharmaceutical logistics – says Veronique Dameme, Head of Global Vertical Market Healthcare at DB Schenker.
When DB Schenker began the certification implementation process, the first goal was to develop a uniform global standard applicable to all modes of transport. This facilitated obtaining GDP certification. Comprehensive certification ensures that processes, infrastructure, and personnel operate in accordance with the rigorous requirements of the pharmaceutical industry by applying the same perfectly developed approach across all units. After the implementation of procedures and the certification process, a risk-based re-audit is conducted based on continuously measured KPIs. It is repeated at least once every 3 years to ensure the maintenance of the highest quality.
DB Schenker constantly analyzes its customers’ demand for these services. Over the next twelve months, the global logistics provider plans to certify more than 180 of its operating units to be able to conduct GDP-certified logistics operations on an even wider scale.







